Ask AI

Advancing Pharmacist Excellence in Solid Tumors: Essential Considerations for Expanding From IV to Subcutaneous ICIs

Enhance your understanding of current and emerging data on subcutaneous immune checkpoint inhibitors used to treat solid tumors to optimize patient-centered care through certified text modules and downloadable slides with notes.

Share

Program Content

Activities

Subcutaneous ICI
Advancing Pharmacist Excellence in Solid Tumors: Essential Considerations for Expanding From IV to Subcutaneous Immune Checkpoint Inhibitors
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 07, 2026

Expires: November 06, 2026

Activities

SC ICI Considerations
SC ICI Delivery Strategies: Practical Considerations for SC Immunotherapies
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: July 09, 2026

Expires: January 08, 2027

SC ICI: Data
SC ICI Delivery Strategies: Supporting Clinical Data for SC Immunotherapies 
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: July 13, 2026

Expires: January 12, 2027

Provided by

ProCE Banner

Provided by ProCE, LLC.

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme LLC